SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

BRIEF-Proteomics International Laboratories Says Seeks FDA Approval For Promarkerd

· 02/07/2021 20:26
BRIEF-Proteomics International Laboratories Says Seeks FDA Approval For Promarkerd

- Proteomics International Laboratories Ltd PIQ.AX:

  • SEEKING ADDITIONAL REGULATORY APPROVAL FOR EASY-TO-USE 'KIT' VERSION OF PROMARKERD FOR DIABETIC KIDNEY DISEASE

Source text for Eikon: ID:nASX7GdSJS

Further company coverage: PIQ.AX


((Reuters.Briefs@thomsonreuters.com;))